BSE Live
Dec 26, 16:01Prev. Close
1737.50
Open Price
1727.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 26, 15:54Prev. Close
1737.00
Open Price
1737.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1719.50 (503)
| Key Financial Ratios of Sun Pharmaceutical Industries (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 43.39 | 61.65 | 48.96 | 32.52 | 24.84 | |
| Diluted EPS (Rs.) | 43.39 | 61.65 | 48.96 | 32.52 | 24.84 | |
| Cash EPS (Rs.) | 46.74 | 64.50 | 51.67 | 34.91 | 27.03 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 276.07 | 248.72 | 203.15 | 126.58 | 78.80 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 276.07 | 248.72 | 203.15 | 126.58 | 78.80 | |
| Dividend / Share(Rs.) | 13.75 | 13.75 | 10.50 | 6.75 | 5.50 | |
| Revenue from Operations/Share (Rs.) | 89.08 | 133.96 | 114.35 | 85.96 | 69.54 | |
| PBDIT/Share (Rs.) | 49.13 | 65.52 | 53.75 | 35.97 | 29.11 | |
| PBIT/Share (Rs.) | 45.77 | 62.68 | 51.05 | 33.57 | 26.91 | |
| PBT/Share (Rs.) | 45.75 | 62.54 | 50.80 | 33.12 | 26.31 | |
| Net Profit/Share (Rs.) | 43.39 | 61.65 | 48.96 | 32.52 | 24.84 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 55.14 | 48.90 | 47.00 | 41.83 | 41.85 | |
| PBIT Margin (%) | 51.38 | 46.78 | 44.63 | 39.05 | 38.70 | |
| PBT Margin (%) | 51.35 | 46.68 | 44.42 | 38.52 | 37.83 | |
| Net Profit Margin (%) | 48.70 | 46.02 | 42.81 | 37.82 | 35.71 | |
| Return on Networth / Equity (%) | 15.71 | 24.78 | 24.10 | 25.68 | 31.51 | |
| Return on Capital Employed (%) | 16.22 | 24.61 | 23.99 | 17.98 | 15.15 | |
| Return on Assets (%) | 13.87 | 20.55 | 18.71 | 16.24 | 12.79 | |
| Total Debt/Equity (X) | 0.01 | 0.00 | 0.02 | 0.44 | 1.19 | |
| Asset Turnover Ratio (%) | 0.29 | 0.48 | 0.51 | 0.44 | 0.38 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.65 | 2.92 | 2.87 | 8.43 | 7.35 | |
| Quick Ratio (X) | 1.75 | 2.40 | 2.49 | 7.14 | 6.50 | |
| Inventory Turnover Ratio (X) | 1.49 | 1.69 | 1.78 | 1.80 | 1.96 | |
| Dividend Payout Ratio (NP) (%) | 31.69 | 22.30 | 21.44 | 20.67 | 22.17 | |
| Dividend Payout Ratio (CP) (%) | 29.41 | 21.31 | 20.32 | 19.25 | 20.37 | |
| Earnings Retention Ratio (%) | 68.31 | 77.70 | 78.56 | 79.33 | 77.83 | |
| Cash Earnings Retention Ratio (%) | 70.59 | 78.69 | 79.68 | 80.75 | 79.63 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 36,908.42 | 21,797.12 | 24,534.86 | 20,251.20 | 16,608.91 | |
| EV/Net Operating Revenue (X) | 20.00 | 7.86 | 10.36 | 12.18 | 12.86 | |
| EV/EBITDA (X) | 36.27 | 16.06 | 22.04 | 29.11 | 30.72 | |
| MarketCap/Net Operating Revenue (X) | 20.09 | 8.30 | 10.77 | 12.26 | 12.46 | |
| Retention Ratios (%) | 68.30 | 77.69 | 78.55 | 79.32 | 77.82 | |
| Price/BV (X) | 6.48 | 4.47 | 6.06 | 8.33 | 11.00 | |
| Price/Net Operating Revenue | 20.09 | 8.30 | 10.77 | 12.26 | 12.46 | |
| Earnings Yield | 0.02 | 0.06 | 0.04 | 0.03 | 0.03 |
20.11.2025
12.11.2025
11.11.2025
Buy Sun Pharmaceutical Industries; target of Rs 1875 Prabhudas Lilladher
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
01.08.2025
Sun Pharma Consolidated June 2025 Net Sales at Rs 13,851.40 crore, up 9.47% Y-o-Y
31.07.2025
Sun Pharma Standalone June 2025 Net Sales at Rs 5,601.96 crore, up 24.54% Y-o-Y
22.05.2025
Sun Pharma Q4 net profit declines 19% to Rs 2,154 crore, firm declares Rs 5.50 dividend